Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Frankincense essential oil, derived from the resin of *Boswellia carterii* (known as Ru Xiang in Chinese), is a natural product being investigated for various therapeutic applications. It is studied for its potential to modulate gene expression and serum protein markers, affect inflammation, and exhibit anti-proliferative and pro-apoptotic activities in cancer cells. Clinical trials are evaluating its efficacy and safety as a dietary supplement for cellular health and inflammation, and as a topical treatment for blepharospasm. One type of supplement being studied combines frankincense essential oil with boswellic acid, while another contains only frankincense essential oil.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on frankincense essential oil.